Xylazine (hydrochloride) 20 mg, excipients q.s. ad 1 mL.
Dormi-Xyl® 2
Injectable Solution
Sedative, analgesic, anesthetic and muscle relaxant
Formulation
Indications
Tranquilizer and analgesic action related to depression of the central nervous system. Its muscle relaxing effect is based on inhibiting the transmission of nerve impulses in the muscle. It produces marked sedation (or only tranquilization) and moderate analgesia for minor interventions. Sedation, analgesia, anesthesia and intense muscular relaxation for very painful interventions (with infiltration or regional anesthesia) or as inductor jointly with other anesthetics (i.e. ketamine).
Dosage and Administration
Cattle: 0.25 - 1.5 mL/100 kg of b.w. through intramuscular route; horses: 3 - 5 mL/100 kg of b.w. through intravenous route; sheep, goats and camelids: 0.15 mL/10 kg of b.w. through intramuscular route; dogs and cats: 0.15 mL/kg of b.w. through intramuscular or intravenous route (this last one recommended in dogs).
Commercial Presentation
Bottle x 10 mL , Bottle x 20 mL , Bottle x 30 mL ,
registro MAGFOR
SENASA Perú: F.23.01.N.0053
MORE VISITED PRODUCTS
ChickVit® ESe OS
Oral SolutionMicroemulsified and Ballanced Association of Vitamin E with Organic Chelated Selenium
